Plasma thrombomodulin in renal disease: effects of renal function and proteinuria

R Rustom1, H Leggat, H R Tomura

  • 1Regional Renal Unit, Liverpool, UK.

Clinical Nephrology
|January 7, 1999
PubMed

Insights

Plasma thrombomodulin (PTM) levels increase with declining kidney function and worsening proteinuria. PTM measurements require adjusted interpretation in patients with renal impairment.

Area of Science:

  • Nephrology
  • Vascular Biology
  • Biochemistry

Background:

  • Plasma thrombomodulin (PTM) is a potential marker for vascular endothelial damage.
  • PTM levels are elevated in active vasculitis.
  • PTM is a mixture of glycoproteins with variable renal excretion, suggesting potential influence of kidney function and proteinuria on its levels.

Purpose of the Study:

  • To investigate the relationship between plasma thrombomodulin levels and renal function.
  • To examine the impact of proteinuria on plasma thrombomodulin levels.
  • To assess how varying renal pathology affects PTM measurements.

Main Methods:

  • PTM levels were measured in 89 renal patients with diverse renal pathologies.
  • Patients included those on hemodialysis (HD) and those with variable renal function and proteinuria.
  • PTM levels were correlated with indicators of renal function and proteinuria.

Main Results:

  • PTM levels demonstrated an inverse correlation with renal function, increasing as kidney function declined.
  • PTM levels were highest in patients undergoing hemodialysis.
  • PTM levels appeared to increase with proteinuria, with a more pronounced effect in hypertensive and diabetic nephropathy compared to primary glomerulonephritis.

Conclusions:

  • Plasma thrombomodulin measurements are significantly influenced by both renal function and proteinuria.
  • Interpretation of PTM levels should consider the degree of renal impairment.
  • Abnormal PTM level thresholds may need adjustment based on declining renal function.

Related Concept Videos

Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.